Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid Arthritis

Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical Practice

NCT01077258 ·Status: COMPLETED

Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis

NCT00049751 ·Status: COMPLETED ·Phase: PHASE3

Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis

NCT00649545 ·Status: APPROVED_FOR_MARKETING

A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis

NCT00448383 ·Status: COMPLETED ·Phase: PHASE3

A Crossover Study of the Safety and Tolerability of Two Formulations of Adalimumab

NCT01502423 ·Status: COMPLETED ·Phase: PHASE2

Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Arthritis

NCT01078571 ·Status: COMPLETED

Real Life Evaluation of Rheumatoid Arthritis in Canadians Taking HUMIRA

NCT01117480 ·Status: COMPLETED

Special Investigation in Patients With Psoriasis Vulgaris and Psoriatic Arthritis (All Patients Investigation)

NCT01155570 ·Status: COMPLETED

Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate

NCT00235859 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients

NCT01001832 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017)

NCT00482417 ·Status: COMPLETED ·Phase: PHASE2

Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab

NCT01273519 ·Status: COMPLETED

A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid Arthritis

NCT00233571 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetics, Safety and Tolerability Study of AVT02 to EU-approved and US-licensed Humira (Adalimumab)

NCT03849313 ·Status: COMPLETED ·Phase: PHASE1

Assessment of the Safety of Adalimumab in Rheumatoid Arthritis Patients Showing Rapid Progression of Structural Damage of the Joints, Who Have no Prior History of Treatment With Disease-modifying Anti-rheumatic Drugs or Biological Agents

NCT01783730 ·Status: COMPLETED

Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

NCT00235833 ·Status: COMPLETED ·Phase: PHASE2

Post-marketing Observational Study in Subjects With Rheumatoid Arthritis

NCT00234884 ·Status: COMPLETED

Safety and Effectiveness and Effect on Quality of Life and Work Productivity of Humira in Patients With Psoriatic Arthritis in Clinical Routine

NCT01078610 ·Status: WITHDRAWN

A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis

NCT00853385 ·Status: COMPLETED ·Phase: PHASE3

A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece

NCT01086033 ·Status: COMPLETED

Crossover Study of Safety and Tolerability of Two Formulations of Adalimumab.

NCT01561313 ·Status: COMPLETED ·Phase: PHASE2

Comparison of the Safety and PK of SYN060 to Humira® in Healthy Adult Subjects

NCT03254810 ·Status: COMPLETED ·Phase: PHASE1

A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis

NCT02019472 ·Status: COMPLETED ·Phase: PHASE3

A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy in Patients With Active Rheumatoid Arthritis

NCT01231321 ·Status: COMPLETED ·Phase: PHASE3

Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic Arthritis

NCT00646386 ·Status: COMPLETED ·Phase: PHASE2